“…Compared with genetic findings in previous GWA studies of BP or BP-I (The Wellcome Trust Case Control Consortium, 2007; Baum et al, 2008; Ferreira et al, 2008; Lee et al, 2011; Kuo et al, 2014; Muhleisen et al, 2014), there are no overlapping genes reported in this GWA study of BP-II. Previous susceptibility loci included ANK3 , ODZ4 , DGKH , SP8 , ST8SIA2 , KCTD12 , CACNB2 , KCNH7 , MYST4 , NRXN3 , SEMA3D , PALB2 , ITIH3 , CACNA1C , among others.…”